Correction to: Journal of Endocrinological Investigation https://doi.org/10.1007/s40618-018-0877-1

Unfortunately, there are errors that occurred in the name and manufacture of the growth hormone (GH) received by the patients in the GH group on page two, Table 1 and Fig. 1 on page three.

The corrections of errors in these sites should be as follows:

  1. 1.

    The trade name and manufacturer of growth hormone (GH) used in the GH group should be “Jintropin AQ, GenSci, Changchun, China”, rather than “Saizen, Kinsey, Changchun, China”.

  2. 2.

    “EMT on day 3 (mm)” should be corrected to “EMT on day of embryo transfer (mm)” in Table 1.

  3. 3.

    “E2 level on 18th day (mmol/L)” should be corrected to “E2 level on 18th day (pg/ml)” in Table 1.

  4. 4.

    “8 clinical pregnancy” should be “10 clinical pregnancy” in Fig 1.